Pharmacokinetic-Pharmacodynamic Modelling of the Antipyretic Effect of Two Oral Formulations of Ibuprofen

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.38, Iss.6, 2000-06, pp. : 505-518

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic-Pharmacodynamic Modelling of the Antihistaminic (H 1 ) Effect of Bilastine

By Jauregizar Nerea

Clinical Pharmacokinetics, Vol. 48, Iss. 8, 2009-08 ,pp. : 543-554

Adis International

Access to resources Recommend Favorite

Biomarkers, Validation and Pharmacokinetic-Pharmacodynamic Modelling

By Colburn W.A.

Clinical Pharmacokinetics, Vol. 42, Iss. 12, 2003-01 ,pp. : 997-1022

Adis International

Access to resources Recommend Favorite

Pharmacokinetic/Pharmacodynamic Modelling in Diabetes Mellitus

By Landersdorfer Cornelia B. Jusko William J.

Clinical Pharmacokinetics, Vol. 47, Iss. 7, 2008-01 ,pp. : 417-448

Adis International

Access to resources Recommend Favorite

Methodological Issues in Pharmacokinetic-Pharmacodynamic Modelling

By Bellissant E.

Clinical Pharmacokinetics, Vol. 35, Iss. 2, 1998-08 ,pp. : 151-166

Adis International

Access to resources Recommend Favorite

Gene Therapy: A Pharmacokinetic/Pharmacodynamic Modelling Overview

By Parra-Guillén Zinnia González-Aseguinolaza Gloria Berraondo Pedro Trocóniz Iñaki

Pharmaceutical Research, Vol. 27, Iss. 8, 2010-08 ,pp. : 1487-1497

Springer Publishing Company

Access to resources Recommend Favorite